Status:
TERMINATED
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
Lead Sponsor:
Emory University
Conditions:
Hematologic Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a study involving patients who are undergoing allogeneic peripheral blood stem cell transplantation. Both donors and recipients are being sought for this study.
Detailed Description
Patients with leukemia will receive a stem cell transplant, prior to which they will receive medication and/or radiation to destroy all leukemia cells as well as other blood cells. In order to survive...
Eligibility Criteria
Inclusion
- All normal donors for patients undergoing allogeneic peripheral blood stem cell (PBSC) for hematologic diseases will be invited to participate in this research trial.
- All patients must meet criteria for transplantation.
- Final eligibility will be determined by the health professionals conducting this clinical trial.
Exclusion
- Donors for patients undergoing selected or manipulated PBSC grafts are not eligible.
- Donors who are pregnant or lactating females and donors with a known hypersensitivity to either G-CSF or GM-CSF will be excluded from this study.
- Final eligibility will be determined by the health professionals conducting this clinical trial.
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00208949
Start Date
September 1 2002
End Date
May 1 2012
Last Update
September 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Winship Cancer Institute
Atlanta, Georgia, United States, 30322